Recently, our research team successfully published a study titled "Controlled Self-Destructive Engineered Bacteria for Effective Immuno-photodynamic Therapy against Melanoma" in Advanced Healthcare Materials (SCI Q2 journal of Chinese Academy of Sciences, TOP journal, 2023-2024 Impact Factor: 10).

    The super aggressive and metastasizing nature of melanoma urgently calls for effective therapeutic scenarios. Recent advances in biohybrids comprising bacteria and chemical substances have demonstrated significant merits in treating cancer by attribute complementation. Here, through bioorthogonal chemistry we covalently anchor our developed photosensitizer (IN) onto the surface of an attenuated Salmonella typhimurium strain (VNP) engineered with the programmed cell death protein 1 (PD-1)-encoding plasmid, creating controlled self-destructive engineered bacteria (VNP-mPD-1@IN). After intravenous injection into B16F10 melanoma-bearing mice, VNP-mPD-1@IN specifically accumulates within the tumor mediated by the hypoxic tropism of VNP, encoding PD-1 within tumor cells and simultaneously triggering partial tumor cell apoptosis due to the self-cytotoxicity of VNP. Once excited by long-wavelength photons, IN on VNP-mPD-1@IN efficiently generates reactive oxygen species, which not only induces the apoptosis of tumor cells, but also triggers bacterial self-destruction to eliminate potential biosafety concerns. The apoptosis of tumor cells leads to considerable immunogenic cell death to reprogram immune environment, which is powered by PD-1-mediated immune checkpoint blockage. As a result, effective immuno-photodynamic therapy is realized to suppress the growth of primary and distant B16F10 tumors as well as prevent their metastasis. Our study sheds light on the remolding of bacteria for effective cancer therapy.

Paper link: https://doi.org/10.1002/adhm.202405210